JP2022501370A5 - - Google Patents

Info

Publication number
JP2022501370A5
JP2022501370A5 JP2021515492A JP2021515492A JP2022501370A5 JP 2022501370 A5 JP2022501370 A5 JP 2022501370A5 JP 2021515492 A JP2021515492 A JP 2021515492A JP 2021515492 A JP2021515492 A JP 2021515492A JP 2022501370 A5 JP2022501370 A5 JP 2022501370A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
hydrogen
cycloalkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021515492A
Other languages
English (en)
Japanese (ja)
Other versions
JP7433303B2 (ja
JP2022501370A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/057814 external-priority patent/WO2020058844A1/en
Publication of JP2022501370A publication Critical patent/JP2022501370A/ja
Publication of JP2022501370A5 publication Critical patent/JP2022501370A5/ja
Application granted granted Critical
Publication of JP7433303B2 publication Critical patent/JP7433303B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021515492A 2018-09-20 2019-09-17 ヒト免疫不全ウイルス複製の阻害剤 Active JP7433303B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862733692P 2018-09-20 2018-09-20
US62/733,692 2018-09-20
PCT/IB2019/057814 WO2020058844A1 (en) 2018-09-20 2019-09-17 Inhibitors of human immunodeficiency virus replication

Publications (3)

Publication Number Publication Date
JP2022501370A JP2022501370A (ja) 2022-01-06
JP2022501370A5 true JP2022501370A5 (https=) 2022-09-05
JP7433303B2 JP7433303B2 (ja) 2024-02-19

Family

ID=68000004

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021515492A Active JP7433303B2 (ja) 2018-09-20 2019-09-17 ヒト免疫不全ウイルス複製の阻害剤

Country Status (4)

Country Link
US (1) US11919897B2 (https=)
EP (1) EP3853228A1 (https=)
JP (1) JP7433303B2 (https=)
WO (1) WO2020058844A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2971987T3 (es) * 2018-10-24 2024-06-10 Viiv Healthcare Uk No 5 Ltd Inhibidores de la replicación del virus de inmunodeficiencia humana
US11541055B2 (en) 2018-10-24 2023-01-03 VIIV Healthcare UK (No.5) Limited Inhibitors of human immunodeficiency virus replication
EP3873607B1 (en) * 2018-10-29 2023-11-29 VIIV Healthcare UK (No.5) Limited Quinazolinyl-indazole derivatives and their use as inhibitors of human immunodeficiency virus replication
EP3914604B1 (en) 2019-01-25 2026-03-04 Brown University Compositions comprising censavudine or elvucitabine for treating age-associated inflammation and disorders
TW202128648A (zh) * 2019-10-04 2021-08-01 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 人類免疫不全病毒複製之抑制劑
EP4066839A4 (en) 2019-11-28 2023-12-27 Shionogi & Co., Ltd PROPHYLACTIC AND THERAPEUTIC MEDICINAL PRODUCT FOR HIV INFECTIOUS DISEASES, CHARACTERIZED BY CONTAINING THE COMBINATION OF INTEGRAS INHIBITORS AND ANTI-HIV AGENTS
KR20220151655A (ko) * 2020-03-06 2022-11-15 비브 헬스케어 유케이 (넘버5) 리미티드 인간 면역결핍 바이러스 복제의 억제제
BR112022020933A2 (pt) * 2020-04-15 2022-12-06 Viiv Healthcare Uk No 5 Ltd Inibidores de replicação do vírus da imunodeficiência humana
US20250042926A1 (en) * 2023-05-31 2025-02-06 Gilead Sciences, Inc. Therapeutic compounds for hiv
CN121335877A (zh) 2023-06-15 2026-01-13 Viiv保健英国第五有限公司 用于制备化合物的方法和中间体
TW202547514A (zh) 2024-02-05 2025-12-16 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 人類免疫不全病毒複製之抑制劑

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008546843A (ja) * 2005-06-27 2008-12-25 アムゲン インコーポレイティッド 抗炎症性アリールニトリル化合物
CN102464654B (zh) 2010-11-12 2016-01-13 上海泓博智源医药技术有限公司 抗病毒化合物
AU2012278976B2 (en) 2011-07-06 2017-05-11 Gilead Sciences, Inc. Compounds for the treatment of HIV
CN102863512B (zh) 2011-07-07 2016-04-20 上海泓博智源医药技术有限公司 抗病毒化合物
ES2642265T3 (es) 2013-01-09 2017-11-16 Gilead Sciences, Inc. Compuestos terapéuticos para el tratamiento de infecciones virales
TW201443037A (zh) 2013-01-09 2014-11-16 Gilead Sciences Inc 治療用化合物
US9220710B2 (en) 2013-01-09 2015-12-29 Gilead Sciences, Inc. Therapeutic compounds
TWI694071B (zh) 2013-03-01 2020-05-21 美商基利科學股份有限公司 治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物
WO2015130966A1 (en) 2014-02-28 2015-09-03 Gilead Sciences, Inc. Antiviral agents
US10202353B2 (en) 2014-02-28 2019-02-12 Gilead Sciences, Inc. Therapeutic compounds
EP3186239B1 (en) 2014-08-29 2018-10-10 Gilead Sciences, Inc. Antiretroviral agents
CN119462611A (zh) 2016-08-19 2025-02-18 吉利德科学公司 用于预防性或治疗性治疗hiv病毒感染的治疗性化合物
TW201906834A (zh) 2017-05-02 2019-02-16 英商Viiv醫療保健英國(No.5)有限公司 人類免疫不全病毒複製之抑制劑
JP7083398B2 (ja) 2018-02-15 2022-06-10 ギリアード サイエンシーズ， インコーポレイテッド ピリジン誘導体およびｈｉｖ感染を処置するためのその使用
EP3752496B1 (en) 2018-02-16 2023-07-05 Gilead Sciences, Inc. Methods and intermediates for preparing a therapeutic compound useful in the treatment of retroviridae viral infection

Similar Documents

Publication Publication Date Title
JP2022501370A5 (https=)
JP2022500425A5 (https=)
JP2022505841A5 (https=)
IL268282B2 (en) hiv inhibitory compounds
JP2022505597A5 (https=)
JP2024508755A5 (https=)
JP2022505989A5 (https=)
JP2016527217A5 (https=)
JP2013209405A5 (https=)
JP2019500387A5 (https=)
JP2021514373A5 (https=)
RU2472509C2 (ru) Способ лечения артрита
JP2013515074A5 (https=)
IL275762B1 (en) Derivatives of phenyl-so2-nh-c(=o)-phenyl-piperazine-ch2-1,2-cyclohexane-bicyclo[1.1.1]pentane and pharmaceutical compositions comprising them
JP2022505637A5 (https=)
JP2019528280A5 (https=)
RU2009102278A (ru) Модуляторы рецептора s1p для лечения рассеянного склероза
JP2024173998A5 (https=)
CA2972014A1 (en) Fused pyrimidine compounds for the treatment of hiv
JP2017537949A5 (https=)
JP2014037426A5 (https=)
JP2016510038A5 (https=)
JP2016518437A5 (https=)
HRP20240501T1 (hr) Derivati pirido[2,3-d]pirimidina kao inhibitori replikacije virusa humane imunodeficijencije
JP2023543059A5 (https=)